275 related articles for article (PubMed ID: 16365293)
1. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice.
Aharoni R; Eilam R; Domev H; Labunskay G; Sela M; Arnon R
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19045-50. PubMed ID: 16365293
[TBL] [Abstract][Full Text] [Related]
2. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ.
Aharoni R; Kayhan B; Eilam R; Sela M; Arnon R
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14157-62. PubMed ID: 14614135
[TBL] [Abstract][Full Text] [Related]
3. Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis.
Aharoni R; Arnon R; Eilam R
J Neurosci; 2005 Sep; 25(36):8217-28. PubMed ID: 16148229
[TBL] [Abstract][Full Text] [Related]
4. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
5. Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.
Moore S; Khalaj AJ; Patel R; Yoon J; Ichwan D; Hayardeny L; Tiwari-Woodruff SK
J Neurosci Res; 2014 Dec; 92(12):1621-36. PubMed ID: 24989965
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate.
Begum-Haque S; Christy M; Ochoa-Reparaz J; Nowak EC; Mielcarz D; Haque A; Kasper LH
J Neuroimmunol; 2011 Mar; 232(1-2):136-44. PubMed ID: 21111489
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate.
Arnon R; Aharoni R
J Neural Transm (Vienna); 2009 Nov; 116(11):1443-9. PubMed ID: 19669693
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications.
Arnon R; Aharoni R
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14593-8. PubMed ID: 15371592
[TBL] [Abstract][Full Text] [Related]
9. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
Kala M; Rhodes SN; Piao WH; Shi FD; Campagnolo DI; Vollmer TL
Exp Neurol; 2010 Jan; 221(1):136-45. PubMed ID: 19879259
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.
Aharoni R; Sasson E; Blumenfeld-Katzir T; Eilam R; Sela M; Assaf Y; Arnon R
Exp Neurol; 2013 Feb; 240():130-44. PubMed ID: 23153580
[TBL] [Abstract][Full Text] [Related]
11. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination.
Lee DH; Geyer E; Flach AC; Jung K; Gold R; Flügel A; Linker RA; Lühder F
Acta Neuropathol; 2012 Feb; 123(2):247-58. PubMed ID: 22009304
[TBL] [Abstract][Full Text] [Related]
13. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor.
Ziemssen T; Kümpfel T; Klinkert WE; Neuhaus O; Hohlfeld R
Brain; 2002 Nov; 125(Pt 11):2381-91. PubMed ID: 12390966
[TBL] [Abstract][Full Text] [Related]
14. Glatiramer acetate could be a hypothetical therapeutic agent for neuromyelitis optica.
Wang KC; Lee CL; Chen SY; Lin KH; Tsai CP
Med Hypotheses; 2011 Jun; 76(6):820-2. PubMed ID: 21398045
[TBL] [Abstract][Full Text] [Related]
15. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis.
Aharoni R; Herschkovitz A; Eilam R; Blumberg-Hazan M; Sela M; Bruck W; Arnon R
Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11358-63. PubMed ID: 18678887
[TBL] [Abstract][Full Text] [Related]
16. Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role.
Liblau R
J Neurol Sci; 2009 Dec; 287 Suppl 1():S17-23. PubMed ID: 20106343
[TBL] [Abstract][Full Text] [Related]
17. Expression of brain-derived neurotrophic factor in astrocytes - Beneficial effects of glatiramer acetate in the R6/2 and YAC128 mouse models of Huntington's disease.
Reick C; Ellrichmann G; Tsai T; Lee DH; Wiese S; Gold R; Saft C; Linker RA
Exp Neurol; 2016 Nov; 285(Pt A):12-23. PubMed ID: 27587303
[TBL] [Abstract][Full Text] [Related]
18. Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis.
Gentile A; Rossi S; Studer V; Motta C; De Chiara V; Musella A; Sepman H; Fresegna D; Musumeci G; Grasselli G; Haji N; Weiss S; Hayardeny L; Mandolesi G; Centonze D
J Neuroimmune Pharmacol; 2013 Jun; 8(3):651-63. PubMed ID: 23370991
[TBL] [Abstract][Full Text] [Related]
19. Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: differential expression of neurotrophic and gliotrophic factors.
Song F; Bandara M; Deol H; Loeb JA; Benjamins J; Lisak RP
J Neuroimmunol; 2013 Sep; 262(1-2):11-8. PubMed ID: 23763772
[TBL] [Abstract][Full Text] [Related]
20. Glatiramer acetate attenuates pro-inflammatory T cell responses but does not directly protect neurons from inflammatory cell death.
Herrmann AM; Göbel K; Simon OJ; Melzer N; Schuhmann MK; Stenner MP; Weishaupt A; Kleinschnitz C; Bittner S; Meuth P; Stuve O; Budde T; Kieseier BC; Wiendl H; Meuth SG
Am J Pathol; 2010 Dec; 177(6):3051-60. PubMed ID: 21037084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
